Hologic Inc (STU:HO1)
€ 72 -4.5 (-5.88%) Market Cap: 16.83 Bil Enterprise Value: 17.02 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 04:00PM GMT
Release Date Price: €47.4 (-0.84%)
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. Good morning. We're going to go ahead and get started. Welcome to day 1 of the conference. I'm Tycho Peterson from the Life Science Tools & Diagnostics team. It's my pleasure to introduce Hologic. We'll do a breakout right after in the Olympic Room. And with that, let me turn it over to Steve.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Thank you, Tycho, and thanks for having us. It's hard to believe, but I first stood up at this stage at this conference 15 years ago as a new CEO, haven't gotten them all right through the years, but I think we've gotten a lot more right than wrong. And as I stand here today, I will tell you this, I am incredibly proud about the state of Hologic's business, and I don't think it's ever been stronger. Each of our businesses, each of our product lines and particularly our leaders of every business in the U.S. and internationally have never been stronger. And that's why we've highlighted and called the title slide today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot